Project Details
Description
IL-15 superagonist ALT 803 maintenance therapy to prevent recurrence of advanced stage ovarian cancer
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/20 → 7/31/22 |
Funding
- MN OVARIAN CANCER ALLIANCE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.